Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Galbreath

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Journal of Contemporary Brachytherapy|January 28, 2016
Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohortsGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
The Journal of Urology|February 19, 2013
Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsyNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
World Journal of Urology|December 1, 2016
Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferationGregory S Merrick, Robert W Galbreath, Abbey Bennett, et al.
Journal of Contemporary Brachytherapy|September 28, 2017
Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSAGregory S Merrick, Robert W Galbreath, Wayne M Butler, et al.
American Journal of Clinical Oncology|December 4, 2004
Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA < 20 ng/mLGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy|April 6, 2004
Biochemical outcome for hormone-naïve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiationGregory S Merrick, Wayne M Butler, Jonathan H Lief, et al.
Brachytherapy|November 4, 2015
Is supplemental external beam radiation therapy essential to maximize brachytherapy outcomes in patients with unfavorable intermediate-risk disease?Gregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.
Cancer Journal (Sudbury, Mass.)|March 16, 2002
Perineural invasion is not predictive of biochemical outcome following prostate brachytherapyGregor S Merrick, Wayne M Butler, Robert W Galbreath, et al.
American Journal of Clinical Oncology|October 15, 2016
Impact of Androgen Deprivation Therapy on Overall Mortality in Prostate Brachytherapy Patients With Low Pretreatment Testosterone LevelsAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Journal of Contemporary Brachytherapy|January 28, 2016
Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohortsGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
The Journal of Urology|February 19, 2013
Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsyNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
World Journal of Urology|December 1, 2016
Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferationGregory S Merrick, Robert W Galbreath, Abbey Bennett, et al.
Journal of Contemporary Brachytherapy|September 28, 2017
Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSAGregory S Merrick, Robert W Galbreath, Wayne M Butler, et al.
American Journal of Clinical Oncology|December 4, 2004
Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA < 20 ng/mLGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy|April 6, 2004
Biochemical outcome for hormone-naïve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiationGregory S Merrick, Wayne M Butler, Jonathan H Lief, et al.
Brachytherapy|November 4, 2015
Is supplemental external beam radiation therapy essential to maximize brachytherapy outcomes in patients with unfavorable intermediate-risk disease?Gregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.
Cancer Journal (Sudbury, Mass.)|March 16, 2002
Perineural invasion is not predictive of biochemical outcome following prostate brachytherapyGregor S Merrick, Wayne M Butler, Robert W Galbreath, et al.
American Journal of Clinical Oncology|October 15, 2016
Impact of Androgen Deprivation Therapy on Overall Mortality in Prostate Brachytherapy Patients With Low Pretreatment Testosterone LevelsAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Pageof 10